CAV1 and psoriasis: Imiquimod (IMQ)-induced psoriasis-like inflammation in mice showed reduced CAV-1 expression in the epidermis and monocytes, and restoration of CAV-1 function improved the severity of skin inflammation and monocyte migration into the dermis (15, 27).